Fractionated Radiation-Induced Dermal Fibrosis

Description

In the fractionated radiation-induced dermal fibrosis model, the back of the mouse is shaved and/or depilated and the skin is temporarily tented such that it can be selectively targeted with radiation while the rest of the mouse is protected by a lead shield. Animals receive 6 fractions of radiation on a schedule of 3 days on, 2 days off. The progression of disease, which can also be observed in an acute radiation model, displays with mild erythema typically observed 8-10 days following radiation exposure, with dermatitis severity peaking between Days 12-16 (depending on the dose of radiation), and with desquamation of approximately 50% of the irradiated area. Peak levels of fibrosis are observed at 36 days following the start of radiation. Endpoints include dermatitis severity scores, collagen content measurement, and histological analyses.

Model Systems
  • BALB/c Mice
Standard Readouts
  • Percent weight change
  • Terminal histopathology and/or IHC analyses
  • Skin collagen content
Additional Readouts
  • Dermatitis severity scores
  • Systemic and tissue cytokine analysis
  • Immunophenotyping
  • Custom assays
Representative DataClick Image to Enlarge
Skin Pathology Dose Response in Fractionated Radiation-Induced Dermal Fibrosis in Mouse

Animals receive a targeted fractionated radiation dose of either 36 Gy, 48 Gy, or 60 Gy to tented back skin, starting on Day 0. At Day 36 skin tissue is collected and processed for histopathology assessment. Representative Masson’s trichrome-stained samples from non-radiated (NR) animals and animals receiving a total dose of radiation of either 36 Gy, 48 Gy, or 60 Gy.

Daniel Lichtman

Managing Partner